These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study. Wolthers OD; Walters EG Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529 [TBL] [Abstract][Full Text] [Related]
26. Reverse water-in-fluorocarbon emulsions for use in pressurized metered-dose inhalers containing hydrofluoroalkane propellants. Butz N; Porté C; Courrier H; Krafft MP; Vandamme TF Int J Pharm; 2002 May; 238(1-2):257-69. PubMed ID: 11996829 [TBL] [Abstract][Full Text] [Related]
27. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC. Vondra V; Sladek K; Kotasová J; Terl M; Rossetti A; Cantini L Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977 [TBL] [Abstract][Full Text] [Related]
28. Application of co-grinding to formulate a model pMDI suspension. Williams RO; Repka MA; Barron MK Eur J Pharm Biopharm; 1999 Sep; 48(2):131-40. PubMed ID: 10469931 [TBL] [Abstract][Full Text] [Related]
29. A comparison of two methods to determine the solubility of compounds in aerosol propellants. Gupta A; Myrdal PB Int J Pharm; 2005 Mar; 292(1-2):201-9. PubMed ID: 15725567 [TBL] [Abstract][Full Text] [Related]
30. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications. Boccuzzi SJ; Wogen J; Roehm JB Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983 [TBL] [Abstract][Full Text] [Related]
31. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma. Gross G; Thompson PJ; Chervinsky P; Vanden Burgt J Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430 [TBL] [Abstract][Full Text] [Related]
32. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant. Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507 [TBL] [Abstract][Full Text] [Related]
33. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. Goldin JG; Tashkin DP; Kleerup EC; Greaser LE; Haywood UM; Sayre JW; Simmons MD; Suttorp M; Colice GL; Vanden Burgt JA; Aberle DR J Allergy Clin Immunol; 1999 Dec; 104(6):S258-67. PubMed ID: 10588987 [TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months. Boulet LP; Cartier A; Ernst P; Larivée P; Laviolette M Can Respir J; 2004 Mar; 11(2):123-30. PubMed ID: 15045043 [TBL] [Abstract][Full Text] [Related]
36. Long-term safety of a non-chlorofluorocarbon-containing triamcinolone acetonide inhalation aerosol in patients with asthma. Azmacort HFA Study Group. Nelson HS; Kane RE; Petillo J; Banerji D J Asthma; 2000 Apr; 37(2):145-52. PubMed ID: 10805203 [TBL] [Abstract][Full Text] [Related]
37. Isothermal microcalorimetry of pressurized systems I: a rapid method to evaluate pressurized metered dose inhaler formulations. D'Sa DJ; Lechuga-Ballesteros D; Chan HK Pharm Res; 2014 Oct; 31(10):2716-23. PubMed ID: 24760449 [TBL] [Abstract][Full Text] [Related]
38. Study of solubility of steroids in hydrofluoroalkane propellants. Williams RO; Rogers TL; Liu J Drug Dev Ind Pharm; 1999 Dec; 25(12):1227-34. PubMed ID: 10612017 [TBL] [Abstract][Full Text] [Related]